Cibc World Markets Corp Arcutis Biotherapeutics, Inc. Transaction History
Cibc World Markets Corp
- $14.8 Billion
- Q2 2025
A detailed history of Cibc World Markets Corp transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 13,197 shares of ARQT stock, worth $328,869. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,197
Previous 23,852
44.67%
Holding current value
$328,869
Previous $373,000
50.4%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARQT
# of Institutions
247Shares Held
132MCall Options Held
407KPut Options Held
216K-
Jennison Associates LLC12.3MShares$305 Million0.14% of portfolio
-
Suvretta Capital Management, LLC New York, NY11.5MShares$287 Million5.56% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$268 Million3.47% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA9.87MShares$246 Million7.3% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$215 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $1.5B
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...